Conmed (NASDAQ:CNMD) will report earnings before markets open on Wednesday, July 24th. CONMED Corporation provides orthopedic products, specializing in arthroscopy and powered surgical instruments. The Company develops, manufactures, and supplies surgical instruments and systems used in a range of surgical procedures. CONMED’s products include arthroscopic surgery devices and powered surgical instruments, electrosurgery systems, and ECG electrodes for heart monitoring.
Here is your Cheat Sheet to Conmed Earnings:
Earnings Expectations: Analysts expect earnings of $0.44 per share on revenues of $193.55 million. Currently, the company’s P/E ratio stands at 23.08.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.43 to a profit $0.42. For the current year, the average estimate is a profit of $1.86, which is the same as the estimate ninety days ago.
Here’s how Conmed has been performing on an annual basis:
|Revenue ($) in millions||742||695||714||725||767|
|Diluted EPS ($)||1.52||0.42||1.05||0.03||1.41|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012||Mar. 31, 2013|
|Revenue ($) in millions||189.70||181.88||201.24||187.01|
|Diluted EPS ($)||0.36||0.32||0.38||0.37|
Conmed has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)